LogoLogo
  • Technology
  • Events
  • Company
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic

Intellectual Property

We Protect our IP!

To ensure our customers interact only with authentic Tixel platforms, we employ advanced digital risk protection to detect and eliminate brand abuse and online threats.

Learn more about BrandShield
Protected by BrandShield

Novoxel Ltd. is renowned for its groundbreaking technology and allocates many resources towards R&D, Intellectual Property and relentless protection of its Intellectual Property rights.

Intellectual Property protection that promotes innovation is central to fulfilling Novoxel®'s mission to offer a better aesthetic dermatologic treatment experience for the benefit of patients and doctors.

Accordingly, Novoxel globally employs a strong intellectual property strategy with a vast portfolio, including but not limited to patents and designs, that support, protect and promote innovation. The protection afforded by strong patents and designs allows Novoxel the readiness to publicly disclose information about its inventions.

The products listed on this website, either alone or in combination with other product(s), are protected by one or more of patents and/or designs. Additional patents and/or designs may be issued and/or pending in the United States or elsewhere.

Patents, Designs & Trademarks

Patents & Inventions

COUNTRY / REGIONPATENT / REGISTRATION NO.
Israel (IL)269610
Israel (IL)279617
Israel (IL)279618
Korea (KR)10-2886697
Israel (IL)217734
USA (US)US 10,702,328 B2
China (CN)ZL 2015 8 0061055.6
Hong Kong (HK)HK40068630
China (CN)ZL 2020 1 0423394.7
Israel (IL)246267
USA (US)US 11,083,515 B2
China (CN)ZL 2020 1 0407250.2
Israel (IL)278403
Japan (JP)7154511
Korea (KR)10-2329660
India (IN)546579
Korea (KR)10-2497377
USA (US)US 11,291,498 B2
Israel (IL)251150
China (CN)ZL 2014 8 0074496.5
Korea (KR)10-2170876
Israel (IL)267166
China (CN)ZL 2018 8 0025322.8
USA (US)US 10,327,832 B2
Japan (JP)7122767
Brazil (BR)BR 112019020202-1
USA (US)US 11,439,455 B2
Europe (EP)EP 3 957 262 B1
Europe (EP)EP 3 082 634
USA (US)US 9,402,678 B2
Europe (EP)EP 2 459 092 B1
China (CN)ZL 2020 8 0049287.0
Japan (JP)7496557
Europe (EP)EP 3 838 208
Europe (EP)EP 3 193 761
Korea (KR)10-2498050
USA (US)US 12,256,980 B2
USA (US)US 12,285,362 B2
Japan (JP)5774001
Canada (CA)111529048
Canada (CA)111616796

Designs

COUNTRY / REGIONPATENT / REGISTRATION NO.
USA (US)US D903,133 S
Korea (KR)30-1000646
EU (EUIPO)004426294-0001
China (CN)ZL 2018 3 0172839.2
USA (US)US D903,132 S
UK90044262940001
EU (EUIPO)005307576-0001/2/3
Korea (KR)30-1027344
China (CN)ZL 2018 3 0301704.1
UK90053075760001
UK90053075760002
UK90053075760003

Trademark Registrations

COUNTRY / REGIONPATENT / REGISTRATION NO.
China (CN)1223249
Canada (CA)TMA1,221,366
EU (OHIM)1223249
Korea (KR)1223249
Taiwan (TW)2209782

Trademarks

Novoxel believes in firm and effective trademark protection. Thus not only patients and professional distributors, but also the public, rely upon trademarks to indicate uncompromising levels of trusted quality, high standards and safety.

Accordingly, Novoxel believes that strict trademark registration and relentless enforcing of its Intellectual Property rights are essential, not only to enable confident commercial decisions and encourage fair competition, but also to protect the health and safety of patients worldwide.

Trademarks must therefore be used properly. As such, please follow these guidelines for legally permitted use of Novoxel's trademarks in all communications, documents and electronic messages. Third-party use of Novoxel's trademarks requires a specific license or prior written permission from Novoxel.

You may refer to Novoxel products and services by their associated Novoxel trademarks as long as such references are truthful, fair and not misleading, and comply with the following guidelines:

  • In the United States, use the appropriate trademark symbol "®" and trademark acknowledgment "™" of Novoxel's ownership of the marks in question, whether word marks or logos, in the first appearance of the trademark in a headline, and/or the first prominent use and first appearance in the body of a text. Outside the United States, use the appropriate trademark attribution notice, for example, "Novoxel and Tixel are trademarks of Novoxel Ltd., registered in the U.S. and other countries."
  • Do not incorporate Novoxel trademarks (of any kind, including word marks and/or logos) into your own product names, service names, trademarks, logos or company names, and do not adopt marks or logos that are confusingly similar to Novoxel's marks.
  • Novoxel trademarks should always be used as an adjective and never as a noun.
  • Never use a Novoxel trademark descriptively or as a play on or pun on the trademark in taglines and/or headlines when referring to the goods and/or services associated with such trademark.
  • Never use a Novoxel trademark as an integrated word of a sentence and never hyphenate or abbreviate Novoxel trademarks.
  • Never incorporate Novoxel trademarks or any part thereof into a third party's company name, service, product brand name or model number.

Please note that such guidelines may be modified by Novoxel from time to time at Novoxel's sole discretion.

Novoxel®
Novoxel®
Tixel®
Tixel®
Tixel i®
Tixel i®
Mezotix®
Mezotix®
Mesotix®
Mesotix®
TMA®
TMA®
Logo

Discover Tixel® powered by TMA® technology. Revolutionary fractional skin resurfacing with maximum safety, minimal side effects. Quick, effective treatments for aesthetic and dry eye applications.

Support
  • Get Support
  • Request a Demo
Product
  • Aesthetics
  • Vision
Company
  • About the Company
  • Contact Us
  • Events
Resources
  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials
Legal
  • Intellectual Property
  • Counterfeit Devices Warning
Regulation
  • Quality Assurance
  • Regulatory Updates

Product

  • Aesthetics
  • Vision

Company

  • About the Company
  • Contact Us
  • Events

Resources

  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials

Support

  • Get Support
  • Request a Demo

Legal

  • Intellectual Property
  • Counterfeit Devices Warning

Regulation

  • Quality Assurance
  • Regulatory Updates

Newsletter

Stay updated with our latest Tixel news.

© 2026 Tixel®, Novoxel®, and TMA®. All rights reserved.

Privacy policyCookie preferences